2Kawai T. Inflammatory markers, especially the mechanism of increased CRP. Rinsho Byon,2000;48(8).
3Headache Classification committee of the international boadache society. Classification and diagnostic criteria for headache disorder, cranial neuralgias and facial pain. Cephalalgia, 1988;8:10.
4Meier EHK,Ridker PM, Rifai N,et al. Absence of diurnal variation of C - reactive protein concentration in healthy human subjects. Clin Chem, 2001;47(3 ):426-430.
5Silberstein SD,Lipton RB.Overview of diagnosis and treatment of migraine[J].Neurology,1994,44(10 Suppl 7):S6-16.
6Kemper RH,Meijler WJ,Korf J,et al.Migraine and function of the immune system a meta-analysis of clinical literature published between 1966 and 1999[J].Cephalalgia,2001,21(5):549-557.
7Kawai T.Inflammatory markers,especially the mechanism of increased CRP[J].Rinsho Byori,2000,48(8):719-721.
8Lange R,Schwarz JA,Hohn M.Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre,randomized,double-blind,single-dose,placebo-controlled,parallel group study[J].Cephalalgia,2000,20(7):663-667.
9Kharbanda RK,Walton B,Allen M,et al.Prevention of inflammation-induced endothelial dysfunction:a novel vasculoprotective action of aspirin[J].Circulation,2002,105(22):2600-2604.
10Meier EHK,Ridker PM,Rifai N,et al. Absence of diurnal variation of C-reactive protein concentration in healthy human subjects[J]. Clin Chem, 2001,47(3):426-430.
